当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:2554.90亿  总市值:3048.91亿
流通股本:24.73亿   总股本:29.52亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润86.60亿元,每股收益3.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益6040908.18万元,未分配利润3664774.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产8382377.99万元,负债2341469.81万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入20,799,281,882.469,654,595,304.2839,241,431,359.8827,702,002,254.76
营业总成本14,014,556,298.926,712,128,987.7227,342,268,206.8819,967,164,047.62
其他经营收益
营业利润9,931,118,357.54,292,748,775.2911,580,174,718.147,890,869,263.36
利润总额9,907,416,557.974,279,893,550.8811,539,811,639.087,854,296,089.21
净利润8,660,348,120.543,715,468,841.049,567,739,539.186,601,611,515.97
每股收益
其他综合收益-37,885,690.49118,473,436.43185,718,884.52-3,353,834.76
综合收益总额8,622,462,430.053,833,942,277.479,753,458,423.76,598,257,681.21
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计42,588,730,423.9943,308,063,148.9438,690,152,263.9930,462,748,877.12
非流动资产:
非流动资产合计41,235,049,478.2541,204,024,944.2941,635,672,144.7643,775,490,998.11
资产总计83,823,779,902.2484,512,088,093.2380,325,824,408.7574,238,239,875.23
流动负债:
流动负债合计20,518,915,049.3418,873,805,072.3216,226,114,890.712,927,421,099.02
非流动负债:
非流动负债合计2,895,783,098.12,859,521,263.65,014,095,882.485,727,576,674.22
负债合计23,414,698,147.4421,733,326,335.9221,240,210,773.1818,654,997,773.24
所有者权益(或股东权益):
归属于母公司股东权益合计59,911,708,305.0362,332,382,757.1158,632,715,174.3755,173,547,660.38
股东权益合计60,409,081,754.862,778,761,757.3159,085,613,635.5755,583,242,101.99
负债和股东权益合计83,823,779,902.2484,512,088,093.2380,325,824,408.7574,238,239,875.23
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计24,056,009,009.6511,640,339,447.6943,465,208,735.1431,246,847,172.83
经营活动现金流出小计16,625,027,477.958,444,909,585.9731,058,693,900.5522,867,754,787.68
经营活动产生的现金流量净额7,430,981,531.73,195,429,861.7212,406,514,834.598,379,092,385.15
投资活动产生的现金流量:
投资活动现金流入小计8,170,088,313.924,078,846,761.7111,987,982,568.265,519,181,400.72
投资活动现金流出小计6,360,546,680.631,879,090,566.0417,506,159,695.018,713,398,273.85
投资活动产生的现金流量净额1,809,541,633.292,199,756,195.67-5,518,177,126.75-3,194,216,873.13
筹资活动产生的现金流量:
筹资活动现金流入小计7,677,208,916.664,767,126,048.911,986,352,535.198,282,155,280.66
筹资活动现金流出小计12,606,536,226.073,531,089,417.3515,818,543,183.2214,187,039,758.56
筹资活动产生的现金流量净额-4,929,327,309.411,236,036,631.55-3,832,190,648.03-5,904,884,477.9
汇率变动对现金及现金等价物的影响-203,423,250.66-61,078,422.61387,525,345.81-9,427,113.53
现金及现金等价物净增加额4,107,772,604.926,570,144,266.333,443,672,405.62-729,436,079.41
期末现金及现金等价物余额17,552,483,822.5620,014,855,483.9713,444,711,217.649,271,602,732.61
补充资料:
现金及现金等价物的净增加额4,107,772,604.92-3,443,672,405.62-
最新报告期:2025-08-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
首创证券王斌5.324.915.612025-08-08
中国银河程培4.945.216.352025-07-31
开源证券汪晋,余汝意4.675.276.252025-07-31
中信证券陈竹,王凯旋,韩世通5.055.236.082025-07-31
兴业证券孙媛媛,黄翰漾5.075.116.022025-07-30
TOP↑